Abstract

Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2018 - Volume 22, Number 5

Page(s): 409

Download in electronic PDF format for $75

Abstract

A formulation for preparing Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2018 Pg. 409	Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Nov/Dec 2006 Pg. 418	Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety Author(s): Fields Shannon W
May/Jun 2017 Pg. 242-246	Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats Author(s): Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
May/Jun 2014 Pg. 253-255	Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2014 Pg. 256-261	Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
May/Jun 2013 Pg. 247-253	Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Jan/Feb 2007 Pg. 73	Fluoxetine Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 248-252	In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream Author(s): Lehman Paul A, Raney Sam G
May/Jun 2009 Pg. 244	Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
May/Jun 2003 Pg. 180-183	The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 242-246	Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Author(s): Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D
Jan/Feb 2012 Pg. 62-63	The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Author(s): Bramwell Bethany L, Williams LaVonn A
May/Jun 2009 Pg. 245	Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 200-203	Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Author(s): Wynn Tom, Goetsch Daniel
Jul/Aug 2021 Pg. 322	BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 569-571	The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel Author(s): Arnold John J, Asbill Scott
Mar/Apr 2019 Pg. 146	Acetaminophen 50% Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr